NASDAQ (USD): VYNE Therapeutics Inc. (VYNE)
Last Price
1.89
Today's Change
-0.03 (1.56%)
Day's Change
1.83 - 1.91
Trading Volume
24,357
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Stock Price
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Manufacturing Mired in Weakness; Prices Paid Gauge Hits Six-month Low
2
US Supreme Court Rules Trump Has Immunity for Official, Not Private Acts
3
BYD Sales Rise to a Record on Price Cuts, Tech Upgrades
4
Morgan Stanley Doing Away With Bonus Caps for City of London Staff
5
Biden Loyalists Dismiss Calls to Quit in Frenetic Weekend Blitz
#
Stock
Score
TQQQ
ProShares UltraPro QQQ
SQQQ
ProShares UltraPro Short QQQ
800
CSLR
Complete Solaria, Inc.
OPTT
Ocean Power Technologies, Inc.
NVDA
NVIDIA Corporation
320
6
AGN
300
7
BAC
Bank of America Corporation
200
8
LGND
Ligand Pharmaceuticals Incorporated
9
AAPL
Apple Inc.
10
BABA
Alibaba Group Holding Limited
140
Last
Change
Volume
0.513
+0.237
477,295,254
TSLA
228.81
+18.95
145,444,407
123.16
-1.14
141,677,391
LMDX
0.016
-0.018
120,553,903
MAXN
0.187
-0.362
104,892,901
RDZN
2.86
+1.24
94,346,905
762.00
-84.71
85,558,284
TSLL
12.16
+1.87
78,186,247
7.98
-0.14
73,883,638
MU
132.23
-10.13
65,857,209
BRK-A
610,640.00
+180.00
1,062
FCNCA
1,733.84
+36.28
28,741
AZO
2,856.83
+24.04
54,292
FNGU
493.78
+20.43
707,333
SMCI
832.58
+20.26
4,246,062
BKNG
3,904.61
+19.73
50,018
ORLY
1,032.599
+16.28
164,480
TDG
1,265.42
+12.70
78,614
WSO
474.32
+12.37
91,045
MSTR
1,065.03
-227.94
2,455,399
MELI
1,629.32
-188.66
1,851,535
MKL
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
MDB
236.06
-73.94
10,812,930
1,016.32
-39.74
532,341
SEB
3,067.00
-37.57
2,023
1,333.00
-32.97
491,414
PVH
108.68
-31.05
6,719,437
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....